HQY

HQY R&D to Revenue

19.99%Fiscal year

Period ending:

HQY FY R&D/Revenue%
HQY FY R&D/Revenue24.03%7.58%
2013-01-312026-01-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

HQY r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 14 observations from Jan 31, 2013 to Jan 31, 2026.

Healthequity Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
19.9866%
19.9632%
21.8901%
22.4399%
20.8%
17.0139%
14.5821%
12.2046%
11.9312%
12.5441%
13.2759%
11.9526%
11.5166%
9.1759%

Compare r&d to revenue

All HQY financial metrics · HQY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.